As shown in Fig. 5g–i, CB0313.1-treated mice exhibited reduced hepatic G6Pase at the protein, mRNA, and enzyme activity levels compared to HF diabetic controls (p = 0.0005, 0.0183, 0.0322, respectively). This evidence concerns the gene G6PC1 and hydrops fetalis.